
Regional Expansion | Stable Patient Pool | Growing Research Capacity
The Mekong Delta, with Can Tho as its central hub, offers strong potential for clinical research with access to large and stable patient populations. Big Leap Research has established collaborations with key hospitals in the region, supporting multi-center studies and expanding recruitment beyond major cities.
Can Tho provides a strategic location for regional studies, supported by well-developed hospitals and increasing clinical research capabilities.
Key hospitals include:
- Can Tho Central General Hospital
- Can Tho General Hospital
- Can Tho Oncology Hospital
- SIS Can Tho (Stroke International Services Hospital)
- Tien Giang General Hospital
These sites provide:
- Access to diverse and community-based patient populations
- Opportunities to support multi-center and regional studies
- Growing capability across key therapeutic areas, including oncology, stroke, endocrinology, nephrology, cardiology, and general medicine
With its expanding infrastructure and strong regional coverage, the Mekong Delta offers reliable recruitment and strong potential for clinical trial expansion in Vietnam.
